Clinical Trial

IP-coated Revision Hip Implants

Study acronym: HIPrevision
Recruiting
View on ClinicalTrials.gov →
Summary
The primary aim of the clinical investigation is to demonstrate the efficacy of a silver-based antimicrobial coating on hip implants in the reduction of periprosthetic infections in revision hip arthroplasty due to periprosthetic infection.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-12-12; most recent amendment 2026-01-09.
Status change: Not Yet Recruiting → Recruiting 2025-06-26
Trial Details
NCT Number NCT06737809
Lead Sponsor Aesculap AG
Conditions Peri-Prosthetic Joint Infection
Enrollment 268 participants
Start Date 2025-06-25
Primary Completion 2027-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-12